Phio Pharmaceuticals (PHIO) News Today $1.67 -0.05 (-2.91%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.70 +0.03 (+1.80%) As of 02/21/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period What is HC Wainwright's Forecast for PHIO FY2024 Earnings?February 22 at 1:21 AM | americanbankingnews.comPhio Pharmaceuticals expands board with new directorFebruary 22 at 12:49 AM | investing.comHC Wainwright Reaffirms "Buy" Rating for Phio Pharmaceuticals (NASDAQ:PHIO)February 21 at 3:37 AM | americanbankingnews.comPhio Pharmaceuticals Appoints David Deming to BoardFebruary 20 at 3:37 PM | tipranks.comPhio Pharmaceuticals files to sell 5.93M shares of common stock for holdersJanuary 23, 2025 | markets.businessinsider.comPhio Pharma (NASDAQ:PHIO) Stock Quotes, Forecast and News SummaryJanuary 14, 2025 | benzinga.comWe Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To RunJanuary 14, 2025 | msn.comPhio Pharma Shares Triple After Positive Trial Data for Cancer TreatmentJanuary 13, 2025 | marketwatch.comPhio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s ElatedJanuary 13, 2025 | msn.comPhio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)October 24, 2024 | theglobeandmail.comPhio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer ConferenceOctober 1, 2024 | finance.yahoo.comUS says navy aeroplane transits Taiwan StraitSeptember 17, 2024 | msn.comPhio Pharmaceuticals Corp. (PHIO)September 15, 2024 | finance.yahoo.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow SeriesAugust 29, 2024 | finanznachrichten.dePhio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To ProfitabilityAugust 27, 2024 | finance.yahoo.comPhio Pharmaceuticals CorpAugust 21, 2024 | morningstar.comPhio Pharmaceuticals appoints new CFOAugust 3, 2024 | uk.investing.comPhio Pharmaceuticals secures investment from TRITON FundsMay 19, 2024 | investing.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Secures New InvestorMay 17, 2024 | finanznachrichten.dePhio Pharmaceuticals Secures New InvestorMay 17, 2024 | globenewswire.comPhio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)May 16, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation StudyMay 15, 2024 | globenewswire.comBuy Rating Affirmed for Phio Pharmaceuticals Amid Promising INTASYL Technology and PH-762 Clinical ProgressMay 15, 2024 | markets.businessinsider.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateMay 10, 2024 | finanznachrichten.dePhio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateMay 9, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)April 30, 2024 | globenewswire.comPhio Pharmaceuticals reports progress on cancer therapy PH-762April 24, 2024 | investing.comWhy Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?April 22, 2024 | benzinga.comIntratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 22, 2024 | finance.yahoo.comIntratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsApril 22, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)April 16, 2024 | globenewswire.comPhio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)April 11, 2024 | globenewswire.comNational Spotlight Features Phio’s Innovative RNAi Technology PlatformApril 3, 2024 | finance.yahoo.comNational Spotlight Features Phio's Innovative RNAi Technology PlatformApril 3, 2024 | globenewswire.comPhio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business UpdateApril 2, 2024 | globenewswire.comPhio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesMarch 21, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity ResearchMarch 13, 2024 | globenewswire.comPhio Pharmaceuticals Corp PHIOMarch 10, 2024 | morningstar.comAnalysts Are Bullish on These Healthcare Stocks: Neurogene (NGNE), Akero Therapeutics (AKRO)March 6, 2024 | markets.businessinsider.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin DisordersMarch 6, 2024 | finance.yahoo.comPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company's Intellectual Property Position in Treating Aging Skin and Skin DisordersMarch 6, 2024 | globenewswire.comDry Age Related Macular Degeneration Market Report 2024: Global Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030February 14, 2024 | uk.finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Phio Pharmaceuticals (PHIO)February 6, 2024 | markets.businessinsider.comPhio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesJanuary 31, 2024 | finance.yahoo.comPhio Pharmaceuticals files to sell 4.42M shares of common stock for holdersDecember 19, 2023 | msn.comWhy Phio Pharmaceuticals Stock Is NosedivingDecember 7, 2023 | msn.comPhio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross ProceedsDecember 7, 2023 | finance.yahoo.comPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | finanznachrichten.dePhio Pharmaceuticals GAAP EPS of -$1.14 beats by $0.29November 10, 2023 | msn.comPhio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 9, 2023 | finance.yahoo.com Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address PHIO Media Mentions By Week PHIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHIO News Sentiment▼0.130.60▲Average Medical News Sentiment PHIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHIO Articles This Week▼40▲PHIO Articles Average Week Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FGEN News Today IMMX News Today LTRN News Today RPTX News Today PRLD News Today KALA News Today CNTB News Today CELU News Today XLO News Today DYAI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHIO Stock Alerts